Prostate Cancer Clinical Trial

Focal Therapy for Localized Prostate Cancer

Summary

This prospective registry is designed to carefully measure details of prostate cancer patients' outcomes with focal therapy so as to understand the impact of various clinical details on the health of patients with the goal of improving patient care.

View Full Description

Full Description

This observational study will serve to collect data from medical record and review questionnaires before and after focal ablation of prostate tissue. All enrolled subjects will have already undergone or scheduled to receive the focal therapy as part of their prostate cancer treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subject has elected or already undergone focal therapy as their standard of care treatment method and declined alternative treatment (active surveillance, radical prostatectomy, and radiation therapy)
PSA ≤ 20
Ability to complete informed consent form

Exclusion Criteria:

Contraindication to follow-up multi parametric MRI or prostate biopsy
Unable to tolerate general or regional anesthesia

Study is for people with:

Prostate Cancer

Estimated Enrollment:

500

Study ID:

NCT06270043

Recruitment Status:

Recruiting

Sponsor:

University of California, San Diego

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California, San Diego
La Jolla California, 92121, United States More Info
Juan Javier-DesLoges, MD
Contact
858-657-8786
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

500

Study ID:

NCT06270043

Recruitment Status:

Recruiting

Sponsor:


University of California, San Diego

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.